Optimize cell and gene therapies with single cell multiomics
One of the more promising types of cancer immunotherapy involves engineering immune cells to recognize and attack cancer. While immune cell therapies like chimeric antigen receptor (CAR) T-cell therapy have been effective for treating some cancers, untangling the mechanisms behind patient response, resistance, and development of toxicities after infusion continues to be a critical focus of ongoing research. Browse this collection of publications to see how researchers are using 10x Genomics technology to study the complexities of cell and gene therapies for treating cancer.
One of the more promising types of cancer immunotherapy involves engineering immune cells to recognize and attack cancer. While immune cell therapies like chimeric antigen receptor (CAR) T-cell therapy have been effective for treating some cancers, untangling the mechanisms behind patient response, resistance, and development of toxicities after infusion continues to be a critical focus of ongoing research. Browse this collection of publications to see how researchers are using 10x Genomics technology to study the complexities of cell and gene therapies for treating cancer.